Search research articles
Contact Us
Filters
Showing results (41-50 of 99) with videos related to
Page
of 10
Sort By:
Journal of Robotic Surgery
|
February 21, 2019
A prospective analysis of robotic targeted MRI-US fusion prostate biopsy using the centroid targeting approach
Saiful Miah, Pol Servian, Amit Patel, et al.
Molecular Oncology
|
May 24, 2025
Simultaneous inhibition of TRIM24 and TRIM28 sensitises prostate cancer cells to antiandrogen therapy, decreasing VEGF signalling and angiogenesis
Damien A Leach, Nilesh Chatterjee, Kellie Spahr, et al.
The Journal of Urology
|
October 6, 2020
Is the Toxicity of Salvage Prostatectomy Related to the Primary Prostate Cancer Therapy Received?
Luis Ribeiro, Thomas Stonier, Luke Stroman, et al.
European Urology Open Science
|
January 3, 2022
A Systematic Review of Patients' Values, Preferences, and Expectations for the Treatment of Metastatic Prostate Cancer
Martin J Connor, Mesfin G Genie, David Burns, et al.
BJU International
|
November 16, 2024
Fluorescence confocal microscopy for margin assessment in prostatectomy: IP8-FLUORESCE study protocol
Nikhil Mayor, Alexander Light, Anna Silvanto, et al.
Journal of Clinical Epidemiology
|
June 2, 2022
Direct mail from primary care and targeted recruitment strategies achieved a representative uptake of prostate cancer screening
David Eldred-Evans, Paula Burak, Natalia Klimowska-Nassar, et al.
European Radiology
|
May 20, 2017
MRI findings in men on active surveillance for prostate cancer: does dutasteride make MRI visible lesions less conspicuous? Results from a placebo-controlled, randomised clinical trial
Francesco Giganti, Caroline M Moore, Nicola L Robertson, et al.
European Urology Oncology
|
April 20, 2023
An Evaluation of Screening Pathways Using a Combination of Magnetic Resonance Imaging and Prostate-specific Antigen: Results from the IP1-PROSTAGRAM Study
David Eldred-Evans, Henry Tam, Heminder Sokhi, et al.
Journal of Magnetic Resonance Imaging : JMRI
|
November 15, 2017
Prostate cancer detection using quantitative T<sub>2</sub> and T<sub>2</sub> -weighted imaging: The effects of 5-alpha-reductase inhibitors in men on active surveillance
Francesco Giganti, Giulio Gambarota, Caroline M Moore, et al.
Prostate Cancer and Prostatic Diseases
|
March 31, 2023
Perceived patient burden and acceptability of MRI in comparison to PSA and ultrasound: results from the IP1-PROSTAGRAM study
David Eldred-Evans, Mathias Winkler, Natalia Klimowska-Nassar, et al.
Page
of 10
Search research articles
Search
Showing results (41-50 of 99) with videos related to
Sort By:
Page
of 10
Journal of Robotic Surgery
|
February 21, 2019
A prospective analysis of robotic targeted MRI-US fusion prostate biopsy using the centroid targeting approach
Saiful Miah, Pol Servian, Amit Patel, et al.
Molecular Oncology
|
May 24, 2025
Simultaneous inhibition of TRIM24 and TRIM28 sensitises prostate cancer cells to antiandrogen therapy, decreasing VEGF signalling and angiogenesis
Damien A Leach, Nilesh Chatterjee, Kellie Spahr, et al.
The Journal of Urology
|
October 6, 2020
Is the Toxicity of Salvage Prostatectomy Related to the Primary Prostate Cancer Therapy Received?
Luis Ribeiro, Thomas Stonier, Luke Stroman, et al.
European Urology Open Science
|
January 3, 2022
A Systematic Review of Patients' Values, Preferences, and Expectations for the Treatment of Metastatic Prostate Cancer
Martin J Connor, Mesfin G Genie, David Burns, et al.
BJU International
|
November 16, 2024
Fluorescence confocal microscopy for margin assessment in prostatectomy: IP8-FLUORESCE study protocol
Nikhil Mayor, Alexander Light, Anna Silvanto, et al.
Journal of Clinical Epidemiology
|
June 2, 2022
Direct mail from primary care and targeted recruitment strategies achieved a representative uptake of prostate cancer screening
David Eldred-Evans, Paula Burak, Natalia Klimowska-Nassar, et al.
European Radiology
|
May 20, 2017
MRI findings in men on active surveillance for prostate cancer: does dutasteride make MRI visible lesions less conspicuous? Results from a placebo-controlled, randomised clinical trial
Francesco Giganti, Caroline M Moore, Nicola L Robertson, et al.
European Urology Oncology
|
April 20, 2023
An Evaluation of Screening Pathways Using a Combination of Magnetic Resonance Imaging and Prostate-specific Antigen: Results from the IP1-PROSTAGRAM Study
David Eldred-Evans, Henry Tam, Heminder Sokhi, et al.
Journal of Magnetic Resonance Imaging : JMRI
|
November 15, 2017
Prostate cancer detection using quantitative T<sub>2</sub> and T<sub>2</sub> -weighted imaging: The effects of 5-alpha-reductase inhibitors in men on active surveillance
Francesco Giganti, Giulio Gambarota, Caroline M Moore, et al.
Prostate Cancer and Prostatic Diseases
|
March 31, 2023
Perceived patient burden and acceptability of MRI in comparison to PSA and ultrasound: results from the IP1-PROSTAGRAM study
David Eldred-Evans, Mathias Winkler, Natalia Klimowska-Nassar, et al.
Page
of 10